Tweetovi

Blokirali ste korisnika/cu @HSaterMD

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @HSaterMD

  1. Prikvačeni tweet
    3. ožu 2018.
    Poništi
  2. proslijedio/la je Tweet

    Wuhan's first hospital built specially for receiving coronavirus patients completed on Sunday after 10 days of speedy construction. It will be managed by China's military medical system and start operation on Monday.

    Poništi
  3. 31. sij

    to report suspected case in . So far 1 case tested negative.

    Poništi
  4. proslijedio/la je Tweet

    Sue Scott describes her cancer journey and participant experience in this video we share for . Watch the full video here:

    Poništi
  5. proslijedio/la je Tweet
    30. sij

    That time when you discover someone in your lab is having too much fun with the annotation tool in the slide viewer. – mjesto: NIH Building 37

    Poništi
  6. proslijedio/la je Tweet

    Why does African Americans have a higher incidence of cancer, lower mortality & an early onset-age across many cancer types? - Work led by Brid Ryan in collab with us found the first hint for it. Just out Tweetorial to summarize.

    Prikaži ovu nit
    Poništi
  7. proslijedio/la je Tweet
    8. sij

    Delighted to see the latest cancer statistics out by showing biggest single year decrease yet. This is largely driven by drops in lung cancer deaths due to smoking cessation. also nice to see the drops in & others.

    Poništi
  8. 7. sij
    Poništi
  9. proslijedio/la je Tweet
    6. sij

    Huge breaking news for Urothelial cancer! Significant OS benefit with switch maintenance avelumab + BSC vs BSC alone after response/SD to 1st line platinum chemotherapy in phase 3 JavelinBladder100 trial!

    Poništi
  10. proslijedio/la je Tweet
    27. pro 2019.

    Published online The trial with 1673 patient volunteers. More data soon from our in-depth analyses of AEs, & of response & toxicity risk

    Poništi
  11. proslijedio/la je Tweet
    26. pro 2019.
    , , i još njih 2
    Poništi
  12. 24. pro 2019.

    Happy Merryplexed Holidays to you and your families!!

    Prikaži ovu nit
    Poništi
  13. proslijedio/la je Tweet
    14. pro 2019.
    Poništi
  14. proslijedio/la je Tweet
    12. pro 2019.

    Dr. Fatima Karzai discusses the evolving role of 🧬in . A study is evaluating patients with Collaboration w/ Trial link:

    , , i još njih 3
    Poništi
  15. proslijedio/la je Tweet
    11. pro 2019.

    You can tell which one is the PI by the extent of the smile! Proud of these investigators!

    Poništi
  16. proslijedio/la je Tweet
    10. pro 2019.

    Twitter facilitates sci working groups/ eg, week pre “Jedi IHC Council” formed in 8d w/members from Singapore/USA/Canada/UK & met in DC

    Prikaži ovu nit
    Poništi
  17. proslijedio/la je Tweet
    8. pro 2019.

    . welcome to Twitter!! Friends, meet Dr. Niglio who is a GU Medical Oncologist Follow him for important updates in .

    Poništi
  18. 8. pro 2019.

    Highly encourage to attend the SITC Cancer Immunotherapy Winter School on Jan. 13–17, 2020, in . This 5-day educational program for young investigators and clinicians will deepen your understanding of .

    Poništi
  19. proslijedio/la je Tweet

    ImmunityBio Granted FDA Breakthrough Therapy Designation for N-803 IL-15 Superagonist in NMI

    Poništi
  20. proslijedio/la je Tweet

    Congratulations to all CCR staff who received Director's Awards. Below are a few of are staff who were in attendance

    Poništi
  21. proslijedio/la je Tweet
    5. pro 2019.

    I might have a “little” bias but I honestly believe that there is no better place then for early investigators. We are particularly passionate about providing support and opportunities for physician-scientists. Welcome!!

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·